Literature DB >> 18826220

Imaging induction of cytoprotective enzymes in intact human cells: coumberone, a metabolic reporter for human AKR1C enzymes reveals activation by panaxytriol, an active component of red ginseng.

Marlin Halim1, Dominic J Yee, Dalibor Sames.   

Abstract

We here present an optical method for monitoring the activity of the inducible aldo-keto reductases AKR1C2 and AKR1C3 in living human cells. The induction of these enzymes is regulated by the antioxidant response element (ARE), as demonstrated in recent literature, which in turn is dependent on the transcription factor Nrf2. The activation of ARE leads to the transcription of a coalition of cytoprotective enzymes and thus represents an important target for the development of new therapies in the area of neurodegenerative diseases and cancer. Through the use of Coumberone, a metabolic fluorogenic probe, and isoform-selective inhibitors, the upregulation of cellular stress markers AKR1C2 and AKR1C3 can be quantitatively measured in the presence of ARE activator compounds, via either a fluorimetric assay or fluorescence microscopy imaging of intact cells. The method has both high sensitivity and broad dynamic range, as demonstrated by induction studies in three cell lines with dramatically different metabolic capabilities (transfected monkey kidney COS-1 cells, human neuroblastoma IMR-32 cells, and human liver HepG2 cells). We applied the new method to examine a number of neurotrophic natural products (spirotenuipesine A, spirotenuipesine B, scabronine G-methylester, and panaxytriol), and discovered that panaxytriol, an active component of red ginseng extracts, is a potent ARE inducer. The upregulation of AKR1C enzymes, induced by chemically homogeneous panaxytriol, was partially dependent on PKC and PI3K kinases as demonstrated by the application of selective inhibitors. This cellular mechanism may account for panaxytriol's neurotrophic, neuroprotective, and anticancer properties. The protective effects of ARE inducers against tumorgenesis and neurodegeneration fuel the growing interest in this area of research and the method described here will greatly enable these endeavors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18826220     DOI: 10.1021/ja801245y

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  12 in total

Review 1.  Natural antioxidants in the treatment and prevention of diabetic nephropathy; a potential approach that warrants clinical trials.

Authors:  Noori Al-Waili; Hamza Al-Waili; Thia Al-Waili; Khelod Salom
Journal:  Redox Rep       Date:  2017-03-09       Impact factor: 4.412

2.  Development of pH-responsive fluorescent false neurotransmitters.

Authors:  Minhee Lee; Niko G Gubernator; David Sulzer; Dalibor Sames
Journal:  J Am Chem Soc       Date:  2010-07-07       Impact factor: 15.419

3.  Pre-clinical activity of PR-104 as monotherapy and in combination with sorafenib in hepatocellular carcinoma.

Authors:  Maria R Abbattista; Stephen M F Jamieson; Yongchuan Gu; Jennifer E Nickel; Susan M Pullen; Adam V Patterson; William R Wilson; Christopher P Guise
Journal:  Cancer Biol Ther       Date:  2015-04-14       Impact factor: 4.742

4.  Multifaceted cytoprotection by synthetic polyacetylenes inspired by the ginseng-derived natural product, panaxytriol.

Authors:  Ting-Chao Chou; Huajin Dong; Xiuguo Zhang; Xiaoguang Lei; John Hartung; Yandong Zhang; Jun Hee Lee; Rebecca M Wilson; Samuel J Danishefsky
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

5.  Enantioselective ProPhenol-catalyzed addition of 1,3-diynes to aldehydes to generate synthetically versatile building blocks and diyne natural products.

Authors:  Barry M Trost; Vincent S Chan; Daisuke Yamamoto
Journal:  J Am Chem Soc       Date:  2010-04-14       Impact factor: 15.419

6.  Activatable Optical Probes for the Detection of Enzymes.

Authors:  Christopher R Drake; David C Miller; Ella F Jones
Journal:  Curr Org Synth       Date:  2011-08       Impact factor: 1.975

7.  Synergistic combination of microtubule targeting anticancer fludelone with cytoprotective panaxytriol derived from panax ginseng against MX-1 cells in vitro: experimental design and data analysis using the combination index method.

Authors:  Ning Zhang; Jia-Ning Fu; Ting-Chao Chou
Journal:  Am J Cancer Res       Date:  2015-12-15       Impact factor: 6.166

8.  Anti-cancer and potential chemopreventive actions of ginseng by activating Nrf2 (NFE2L2) anti-oxidative stress/anti-inflammatory pathways.

Authors:  Constance Lay-Lay Saw; Qing Wu; Ah-Ng Tony Kong
Journal:  Chin Med       Date:  2010-10-27       Impact factor: 5.455

9.  Identification of a gene signature of a pre-transformation process by senescence evasion in normal human epidermal keratinocytes.

Authors:  Nathalie Martin; Clara Salazar-Cardozo; Chantal Vercamer; Louise Ott; Guillemette Marot; Predrag Slijepcevic; Corinne Abbadie; Olivier Pluquet
Journal:  Mol Cancer       Date:  2014-06-14       Impact factor: 27.401

10.  Cisplatin resistance by induction of aldo-keto reductase family 1 member C2 in human bladder cancer cells.

Authors:  Akitomi Shirato; Tadahiko Kikugawa; Noriyoshi Miura; Nozomu Tanji; Nobuaki Takemori; Shigeki Higashiyama; Masayoshi Yokoyama
Journal:  Oncol Lett       Date:  2013-12-19       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.